• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYC
Click for more information
3.45% 14.0¢

PYC THERAPEUTICS LIMITED

Market Cap $653.2M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PYC
PYC - General Discussion
7 8 9
20/09/24 497 235K
20/09/24 Last post  Fat Harrys Cat Comments Created with Sketch.  497  Views Created with Sketch.  235K 
PYC
PYC Chart and Technical Analysis
2 3 4
18/09/24 204 96K
18/09/24 Last post  Fat Harrys Cat Comments Created with Sketch.  204  Views Created with Sketch.  96K 
PYC
A clue to a deal 		07/09/24 15 8.3K
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

Read More   right-arrow Created with Sketch.
BPM
20 Sep 2024
BPM MINERALS LIMITED
07/09/24 Last post  hottod Comments Created with Sketch.  15  Views Created with Sketch.  8.3K 
PYC
Ann: FDA Grants Rare Pediatric Disease Designation to PYC-001 		02/09/24 15 6.8K
02/09/24 Last post  brrrattt Comments Created with Sketch.  15  Views Created with Sketch.  6.8K 
PYC
Ann: Q3 2024 Investor Webinar Presentation 		02/09/24 17 7.0K
02/09/24 Last post  Linsanity Comments Created with Sketch.  17  Views Created with Sketch.  7.0K 
PYC
Ann: Appendix 4E and Audited Financial Statements 		29/08/24 0 510
29/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  510 
PYC
Ann: Q3 Investor Webinar 30 August 2024 		26/08/24 14 7.9K
26/08/24 Last post  Fat Harrys Cat Comments Created with Sketch.  14  Views Created with Sketch.  7.9K 
PYC
Ann: PYC to Start Human Trials in Second Blinding Eye Disease 		15/08/24 2 1.6K
15/08/24 Last post  ASX News Comments Created with Sketch.  2  Views Created with Sketch.  1.6K 

See All Discussions arrow Created with Sketch.

Timeline

FDA Grants Rare Pediatric Disease Designation to PYC-001
30 Aug 08:26
 
Q3 2024 Investor Webinar Presentation
30 Aug 08:08
 
Appendix 4E and Audited Financial Statements
29 Aug 17:15
 
Q3 Investor Webinar 30 August 2024
22 Aug 10:49
 
PYC to Start Human Trials in Second Blinding Eye Disease
15 Aug 08:57
 
Canaccord Genuity Growth Conference Presentation
13 Aug 09:03
 
View More arrow Created with Sketch.

Featured News

NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.

(20min delay)
Last
14.0¢ 		Change
-0.005(3.45%) 		Mkt cap ! $653.2M
Open High Low Value Volume
14.5¢ 14.5¢ 13.5¢ $480.6K 3.448M

Buyers (Bids)

No. Vol. Price($)
7 368663 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 525796 8
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
13.8¢ 		  Change
-0.005 ( 4.98 %)
Open High Low Volume
14.0¢ 14.0¢ 13.5¢ 1280632
Last updated 15.51pm 20/09/2024 ?
PYC (ASX) Chart

Top Stories

Week 38 Wrap: US markets panic at 50bp cut; ALS’s minerals revenue  slowdown; RBA path unclear

Well, it finally happened – the US Fed cut interest rates this week, and we got a double dose: a whole -50bps knocked off.
Harvey Norman hit with a second class action – and shareholders, once again, don't care Harvey Norman (ASX:HVN) has confirmed it's been hit by a second class action this week over allegedly dodgy warranty cover – and the stock is up +1.23 at 11.15am Sydney time.
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025 Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.

Featured News

NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.